Neogen (NEOG) Net Cash Flow Growth (3y) (2013 - 2026)
Neogen (NEOG) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 269.22% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | -35.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -35.85% |
| Feb 28, 2026 | 32.32% |
| Nov 30, 2025 | 51.38% |
| Aug 31, 2025 | -48.79% |
| May 31, 2025 | -38.99% |
| Feb 28, 2025 | -16.88% |
| Nov 30, 2024 | 49.81% |
| Aug 31, 2024 | -253.13% |
| May 31, 2024 | 108.97% |
| Feb 29, 2024 | -3.63% |
| Nov 30, 2023 | -20.07% |
| Aug 31, 2023 | 68.64% |
| May 31, 2023 | 87.38% |
| Feb 28, 2023 | -37.38% |
| Nov 30, 2022 | -36.70% |
| Aug 31, 2022 | 58.85% |
| May 31, 2022 | 26.91% |
| Feb 28, 2022 | 7.70% |
| Nov 30, 2021 | -112.95% |
| Aug 31, 2021 | -27.36% |